Fresenius Kabi debuts generic Bentyl

Fresenius Kabi is introducing dicyclomine hydrochloride injection, in a 20 mg per 2 mL single-dose vial. The product is the generic of Aptalis Pharma Canada's Bentyl.

Dicyclomine hydrochloride injection is an antispasmodic and anticholinergic agent indicated for the treatment of functional bowel and irritable bowel syndrome.

“Fresenius Kabi is pleased to announce the availability of this latest addition to our critical care portfolio, representing another important and affordable therapy option for clinicians and the patients they treat,” said John Ducker, Fresenius Kabi USA president and CEO.